How Cutaneous Lymphoma Patients May Be Impacted by COVID-19 Vaccines | CheckRare
Susan Thornton, CEO of Cutaneous Lymphoma Foundation, discusses how the cutaneous lymphoma community may be impacted by potential COVID-19 vaccines.
Susan Thornton, CEO of Cutaneous Lymphoma Foundation, discusses how the cutaneous lymphoma community may be impacted by potential COVID-19 vaccines.
We have noticed an unusual activity from your IP 199.16.157.180 and blocked access to this
Treatment with NALL for 12 weeks yields better neurological status than placebo among patients with Niemann-Pick disease type C.
Cat Lutz, PhD, MBA, VP at JAX Rare Disease Translational Center, discusses rare disease research’s impact on understanding common diseases.
Bill Grambley explains how his company attacks health inequalities by providing personalized pharmaceutical care with an AI based platform.
We have noticed an unusual activity from your IP 192.133.77.15 and blocked access to this
We have noticed an unusual activity from your IP 199.16.157.181 and blocked access to this
This symposium, led by Ozlem Goker-Alpan, MD of the Lysosomal & Rare Disorders Research & Treatment Center (LDRTC) reviews the current state of newborn screening…
Rett syndrome is a multisystem disorder that primarily affects girls; multiple loss-of-function mutations to the MECP2 gene are the cause of this rare disease.
Brahm Goldstein, MD, Vice President, R&D, Hematology at CSL Behring, discusses HEMGENIX, a pivotal gene therapy for hemophilia B.
We have noticed an unusual activity from your IP 199.16.157.183 and blocked access to this